These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17176481)

  • 21. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.
    Kerr T; Wood E; Small D; Palepu A; Tyndall MW
    CMAJ; 2003 Oct; 169(8):759-63. PubMed ID: 14557313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility.
    Fairbairn N; Small W; Shannon K; Wood E; Kerr T
    Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs.
    Ti L; Buxton J; Harrison S; Dobrer S; Montaner J; Wood E; Kerr T
    J Hosp Med; 2015 May; 10(5):301-6. PubMed ID: 25754871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Employment among users of a medically supervised safer injection facility.
    Richardson L; Wood E; Zhang R; Montaner J; Tyndall M; Kerr T
    Am J Drug Alcohol Abuse; 2008; 34(5):519-25. PubMed ID: 18821450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with sex trade involvement among male participants in a prospective study of injection drug users.
    Kuyper LM; Lampinen TM; Li K; Spittal PM; Hogg RS; Schechter MT; Wood E
    Sex Transm Infect; 2004 Dec; 80(6):531-5. PubMed ID: 15572630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.
    Wood E; Tyndall MW; Zhang R; Montaner JS; Kerr T
    Addiction; 2007 Jun; 102(6):916-9. PubMed ID: 17523986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis.
    Kennedy MC; Hayashi K; Milloy MJ; Boyd J; Wood E; Kerr T
    Int J Drug Policy; 2020 Apr; 78():102692. PubMed ID: 32200269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies.
    Werb D; Kerr T; Small W; Li K; Montaner J; Wood E
    J Public Health (Oxf); 2008 Jun; 30(2):126-32. PubMed ID: 18387974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
    Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
    Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.
    Lloyd-Smith E; Wood E; Li K; Montaner JS; Kerr T
    Drug Alcohol Depend; 2009 Jan; 99(1-3):176-82. PubMed ID: 18805655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.
    Collins CL; Kerr T; Kuyper LM; Li K; Tyndall MW; Marsh DC; Montaner JS; Wood E
    J Urban Health; 2005 Jun; 82(2):276-84. PubMed ID: 15872188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
    Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
    Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
    DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
    J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with public injecting among users of Vancouver's supervised injection facility.
    McKnight I; Maas B; Wood E; Tyndall MW; Small W; Lai C; Montaner JS; Kerr T
    Am J Drug Alcohol Abuse; 2007; 33(2):319-25. PubMed ID: 17497555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.